Company Quick10K Filing
Aura Systems
10-K 2021-02-28 Filed 2021-06-01
10-Q 2020-11-30 Filed 2021-01-19
10-Q 2020-08-31 Filed 2020-10-23
10-Q 2020-05-31 Filed 2020-07-20
10-K 2020-02-29 Filed 2020-07-13
10-Q 2019-11-30 Filed 2020-01-14
10-Q 2019-08-31 Filed 2019-11-14
10-Q 2019-05-31 Filed 2019-10-29
10-K 2019-02-28 Filed 2019-06-13
10-Q 2018-11-30 Filed 2019-01-22
10-Q 2018-08-31 Filed 2018-10-22
10-Q 2018-05-31 Filed 2018-07-11
10-K 2018-02-28 Filed 2018-06-13
10-Q 2017-11-30 Filed 2018-01-19
10-Q 2017-08-31 Filed 2017-10-25
10-Q 2017-05-31 Filed 2017-10-25
10-K 2017-02-28 Filed 2017-09-18
10-Q 2016-11-30 Filed 2017-09-18
10-Q 2016-08-31 Filed 2017-09-18
10-Q 2016-05-31 Filed 2017-09-18
10-K 2016-02-29 Filed 2017-09-18
10-Q 2015-11-30 Filed 2017-09-18
10-Q 2015-08-31 Filed 2017-09-18
10-Q 2015-05-31 Filed 2017-09-18
10-K 2015-02-28 Filed 2017-09-18
10-Q 2014-11-30 Filed 2015-01-16
10-Q 2014-08-31 Filed 2014-10-15
10-Q 2014-05-31 Filed 2014-07-15
10-K 2014-02-28 Filed 2014-06-13
10-Q 2013-11-30 Filed 2014-01-21
10-Q 2013-08-31 Filed 2013-10-21
10-Q 2013-05-31 Filed 2013-07-22
10-K 2013-02-28 Filed 2013-06-12
10-Q 2012-11-30 Filed 2013-01-14
10-Q 2012-08-31 Filed 2012-10-15
10-Q 2012-05-31 Filed 2012-07-13
10-K 2012-02-29 Filed 2012-05-29
10-Q 2011-11-30 Filed 2012-01-17
10-Q 2011-08-31 Filed 2011-10-17
10-Q 2011-05-31 Filed 2011-07-15
10-K 2011-02-28 Filed 2011-06-14
10-Q 2010-11-30 Filed 2011-01-19
10-Q 2010-08-31 Filed 2010-10-20
10-Q 2010-05-31 Filed 2010-07-16
10-K 2010-02-28 Filed 2010-06-16
10-Q 2009-11-30 Filed 2010-01-15
8-K 2020-05-28
8-K 2020-01-10
8-K 2019-10-18
8-K 2019-07-11
8-K 2019-07-09
8-K 2019-06-04
8-K 2018-08-15
8-K 2018-07-03
8-K 2018-04-05
8-K 2018-03-30
8-K 2018-03-28
8-K 2018-03-28
8-K 2018-03-26
8-K 2018-03-23
8-K 2018-03-22
8-K 2018-03-15
8-K 2018-02-14
8-K 2018-02-13
8-K 2018-02-12
8-K 2018-01-11

Aura Systems Financials

AUSI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
1347 Capital Corp (TFSC)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
Ameren Illinois Co (AILNP)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-05-31
Cash531466113939891432584110115355374223574331112569751,0641,178748197532111
Accounts Receivable4825477957411187412803905365731261635859532682000031
Inventory1,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0000000000000
PP&E2892431981531,6121,6121,6121,6121,6121,1271,1271,1271,1271,1271,1271,1271,1271,1271,1271,1271,1271,127
Assets4,6054,6204,1393,8223,3803,6833,0902,9323,0493,2011,4961,6121,2782551792031991313674421182621,2341,3451,4381,040516327322308
Accounts Payable1,5086257719659279841,2021,1749441,5601,9811,4791,9541,8892,6322,1532,1501,8242,2932,4022,4124,9444,5014,4894,8285,3774,9605,1755,4272,516
Long-Term Debt1,4511,1203,0253,0541,1881,2555,9416,1477,8758,0158,2938,4818,5748,9949,4339,54810,0435,6365,5865,5865,5865,484
Liabilities14,64413,54615,73818,17320,37922,47224,68925,18427,30830,00132,66933,33936,84938,82140,98642,58944,24245,30146,84947,97948,72953,06954,25655,53857,29225,70625,40623,59624,75722,528
Stockholders' Equity-10,039-8,926-11,599-14,351-16,999-18,788-21,598-22,252-24,259-26,800-31,173-31,727-35,571-38,565-40,807-42,386-44,043-45,170-46,482-47,537-48,611-52,806-53,022-54,192-55,854-24,665-24,890-23,225-24,435-22,220
Income Statement ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-05-31
Revenue6165271,2427683041,215431809615853614501,0411141061013818300000037200
Cost of Revenue3333427743531076454233203123421,189210975-307440570000001558370
Gross Profit2821854684141975708488304511-1,128240671443361-1900000023-56370
R&D382338335316380312305399305387204304163171379510534000025771333113844
SG&A5,6982,8962,3042,3002,2273,4975,3532,5652,2741,8472,3153,1241,2961,3451,4567897356172314712,2035683638234,0501,0023,041791314
Tax0000000000000000000000
Net Income-5,800-3,273-3,054-3,082-3,348-2,153-6,566-2,979-3,731-2,583-4,567-4,008-2,109-2,064-2,242-1,579-1,657-1,407-1,055-1,074-2,383-1,171-1,6626,916-1,036-3,405-1,310-675
Cash Flow ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-05-31
Cash Operating-2,962-1,240-1,183-1,710-1,249-2,019-1,651-2,268-1,310-634-2,144-20-316-764-923-98-132-213-1,0644,169-4,874-1,001-769-397
Cash Investing-25000
Cash Financing3,0551,1001,1881,7381,2482,0691,5762,2851,3366172,203403344013384332073582,03245050